Merck Stock: Pipeline Building Despite The Light FY26 Guide, Major Momentum (NYSE:MRK)

Core Insights - Merck (MRK) reported strong Q4 earnings, achieving a double beat that went largely unnoticed due to the focus on the Magnificent Seven earnings, yet the stock performance was notable [1] Financial Performance - Merck's market capitalization is now $305 billion, indicating significant growth and stability in the health sector [1]